The anti‐epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA‐ and glycine‐gated currents

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Pharmacology

• Publication date

  2002-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0704766PMID 12086975PMCID PMC1573396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Do Antiepileptics Phenytoin, Carbamazepine, and Loreclezole Show GABAA Receptor Subtype Selectivity in Rat Brain Sections?

  2004cited by this paper
• Subunit composition of strychnine‐sensitive glycine receptors expressed by adult rat basolateral amygdala neurons

  2001cited by this paper
• Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents.

  2001cited by this paper
• Expression and function of glycine receptors in striatal cholinergic interneurons from rat and mouse.

  2001cited by this paper
• A nonsense mutation in the alpha1 subunit of the inhibitory glycine receptor associated with bovine myoclonus.

  2001cited by this paper
• Disorders of membrane channels or channelopathies.

  2001cited by this paper
• The inhibitory neural circuitry as target of antiepileptic drugs.

  2001cited by this paper
• Genetic variation of the human glycine receptor subunit genes GLRA3 and GLRB and susceptibility to idiopathic generalized epilepsies.

  2001cited by this paper
• Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

  2000influential reference
• Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms

  2000cited by this paper
• What is GABAergic Inhibition? How Is it Modified in Epilepsy?

  2000cited by this paper
• Antiepileptic efficacy of topiramate: assessment in two in vitro seizure models.

  2000cited by this paper
• Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices.

  2000cited by this paper
• Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs.

  2000influential reference
• Mechanisms of action of anticonvulsant agents.

  2000cited by this paper
• Mossy Fiber Zinc and Temporal Lobe Epilepsy: Pathological Association with Altered “Epileptic”γ‐Aminobutyric Acid A Receptors in Dentate Granule Cells

  2000cited by this paper
• Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.

  1999cited by this paper
• Inhibitory Effect of Ondansetron on Glycine Response of Dissociated Rat Hippocampal Neurons 1

  1999cited by this paper
• The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating.

  1999cited by this paper
• GLYCINE RECEPTORS: WHAT GETS IN AND WHY?

  1999cited by this paper
• Chronic Epileptogenic Cellular Alterations in the Limbic System After Status Epilepticus

  1999cited by this paper
• Inhibitory effect of ondansetron on glycine response of dissociated rat hippocampal neurons.

  1999cited by this paper
• Zinc Inhibition of γ-Aminobutyric AcidA Receptor Function Is Decreased in the Cerebral Cortex during Pilocarpine-Induced Status Epilepticus

  1999cited by this paper
• Zinc inhibition of gamma-aminobutyric acid(A) receptor function is decreased in the cerebral cortex during pilocarpine-induced status epilepticus.

  1999cited by this paper
• Identification of an inhibitory Zn2+ binding site on the human glycine receptor α1 subunit

  1999cited by this paper
• An update on GABAA receptors.

  1999cited by this paper
• Structure and Functions of Inhibitory and Excitatory Glycine Receptors

  1999cited by this paper
• On the Action of the Anti-Absence Drug Ethosuximide in the Rat and Cat Thalamus

  1998cited by this paper
• Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.

  1998cited by this paper
• Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.

  1998influential reference
• Multiple picrotoxinin effect on glycine channels in rat hippocampal neurons.

  1998cited by this paper
• Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.

  1997cited by this paper
• Embryonic rat spinal cord neurons change expression of glycine receptor subtypes during development in vitro.

  1997cited by this paper
• Physiological and pharmacological alterations in postsynaptic GABA(A) receptor function in a hippocampal culture model of chronic spontaneous seizures.

  1997cited by this paper
• The initiating stimuli for uveitis

  1997cited by this paper
• Inhibition by levetiracetam of a non‐GABAA receptor‐associated epileptiform effect of bicuculline in rat hippocampus

  1997cited by this paper
• Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

  1997cited by this paper
• Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission

  1997influential reference
• The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.

  1996cited by this paper
• Cerebellar granule cells in vitro recapitulate the in vivo pattern of GABAA-receptor subunit expression.

  1995cited by this paper
• Heterogeneous current responses to GABA and glycine are present in post-natally cultured hippocampal neurons.

  1995cited by this paper
• The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.

  1995influential reference
• Whole‐cell and single‐channel currents activated by GABA and glycine in granule cells of the rat cerebellum.

  1995cited by this paper
• From ion currents to genomic analysis: Recent advances in GABAA receptor research

  1995cited by this paper
• Differential Effects of 4′‐Chlorodiazepam on Expressed Human GABAA Receptors

  1995cited by this paper
• Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.

  1995cited by this paper
• Amino acid‐induced responses in CNS neurones of normal mouse and Wriggle Mouse Sagami

  1994cited by this paper
• Astroglia‐released factor shows similar effects as benzodiazepine inverse agonists

  1994influential reference
• Developmental alteration in GABAA receptor structure and physiological properties in cultured cerebellar granule neurons.

  1994cited by this paper
• Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc.

  1994cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.

  1993cited by this paper
• GABA and epilepsy: basic concepts from preclinical research.

  1992cited by this paper
• ucb L059, a novel anti-convulsant drug: pharmacological profile in animals.

  1992cited by this paper
• Cultured astroglia release a neuronotoxic activity that is not related to the excitotoxins.

  1989cited by this paper
• Differences in the negative allosteric modulation of gamma-aminobutyric acid receptors elicited by 4'-chlorodiazepam and by a beta-carboline-3-carboxylate ester: a study with natural and reconstituted receptors.

  1989cited by this paper
• Expression of Functional Human Monoamine Oxidase A and B cDNAs in Mammalian Cells

  1989cited by this paper
• n‐[3H]Butyl‐β‐Carboline‐3‐Carboxylate, a Putative Endogenous Ligand, Binds Preferentially to Subtype 1 of Central Benzodiazepine Receptors

  1989cited by this paper
• Regional distribution of a Ro5 4864 binding site that is functionally coupled to the gamma-aminobutyric acid/benzodiazepine receptor complex in rat brain.

  1988cited by this paper
• Potassium-induced release of neuronotoxic activity by astrocytes.

  1987cited by this paper
• Isolation and identification in bovine cerebral cortex of n-butyl beta-carboline-3-carboxylate, a potent benzodiazepine binding inhibitor.

  1986cited by this paper
• Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study.

  1983cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Kainic acid as a tool for the study of temporal lobe epilepsy

  1981cited by this paper
• Minireview. Kainic acid as a tool for the study of temporal lobe epilepsy.

  1981cited by this paper
• Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.

  1980cited by this paper
• Growth of a rat neuroblastoma cell line in serum-free supplemented medium.

  1979cited by this paper

• Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

  2026cites this paper
• Exploring the supraspinal antihyperalgesic effects of levetiracetam in the rat model of chronic constriction injury.

  2025cites this paper
• Effects of levetiracetam an antiepileptic drug on the multi-biological parameters in African catfish Clarias gariepinus (Burchell, 1822)

  2025cites this paper
• ADHD-like behaviors in adolescent mice prenatally exposed to levetiracetam: No safe gestational dose across sexes.

  2025cites this paper
• Principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam using the food and drug administration adverse event reporting system.

  2025cites this paper
• A Review of Analytical Method Development and Validation of Levetiracetam

  2024cites this paper
• Behavioral and neurotransmitter changes on antiepileptic drugs treatment in the zebrafish pentylenetetrazol-induced seizure model.

  2024cites this paper
• Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review

  2024cites this paper
• Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database.

  2024cites this paper
• Evaluating the Efficacy of Levetiracetam on Non-Cognitive Symptoms and Pathology in a Tau Mouse Model

  2024cites this paper
• Oligoprotective Activity of Levetiracetam Against Glutamate Toxicity: An in vitro Study.

  2024cites this paper
• The role of neurotransmitters in glioblastoma multiforme‐associated seizures

  2023cites this paper
• Levetiracetam, from broad-spectrum use to precision prescription: A narrative review and expert opinion.

  2023cites this paper
• Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits

  2023cites this paper
• Usefulness of Remimazolam for Anesthesia Management of Kidney Transplantation in a Patient with Cognitive Decline: A Case Report

  2023cites this paper
• Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil

  2023cites this paper
• Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study

  2023cites this paper
• Pharmacological treatment of Tourette’s syndrome: from the past to the future

  2023cites this paper
• Levetiracetam or Phenobarbitone as a First-Line Anticonvulsant in Asphyxiated Term Newborns? An Open-Label, Single-Center, Randomized, Controlled, Pragmatic Trial.

  2022cites this paper
• Brivaracetam for the treatment of refractory epilepsy in patients with prior exposure to levetiracetam: A retrospective outcome analysis.

  2022cites this paper
• Levetiracetam Mechanisms of Action: From Molecules to Systems

  2022influential citation
• Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care – an overview

  2022cites this paper
• Perinatal hypoxia and thalamus brain region: increased efficiency of antiepileptic drug levetiracetam to inhibit GABA release from nerve terminals

  2022cites this paper
• DEPRESSION-LIKE EFFECTS OF LEVETIRACETAM WAS HALTED BY PRETREATMENT WITH N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) BLOCKERS IN MICE

  2022cites this paper
• Review on bioanalytical and analytical method development of Antiepileptic racetams

  2022cites this paper
• Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes

  2022cites this paper
• Caffeine impairs anticonvulsant effects of levetiracetam in the maximal electroshock seizure threshold test in mice

  2022cites this paper
• Modulation of nociception and pain-evoked neurobehavioral responses by levetiracetam in a craniotomy pain model.

  2021cites this paper
• Investigating Neuroprotective Potential of Berberine, Levetiracetam and Their Combination in The Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.

  2021cites this paper
• Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish.

  2021cites this paper
• The effect of complicated febrile convulsion on hippocampal function and its antiepileptic treatment significance

  2021cites this paper
• Therapeutic Options for Childhood Absence Epilepsy

  2021cites this paper
• Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults

  2021cites this paper
• Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: preclinical and clinical data.

  2021cites this paper
• ADVERSE EFFECTS OF ANTIEPILEPTIC DRUGS ON HORMONES OF THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALES: A REVIEW.

  2021cites this paper
• Safety considerations selecting antiseizure medications for the treatment of individuals with Dravet syndrome

  2021cites this paper
• Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy

  2020cites this paper
• The adverse effects of psychotropic drugs as an endocrine disrupting chemicals on the hypothalamic-pituitary regulation in male.

  2020cites this paper
• Advance on synthesis, pharmacokinetics, and pharmacodynamics of the anti-epileptic drug: Levetiracetam

  2020cites this paper
• Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy

  2020cites this paper
• Mechanisms of action of currently used antiseizure drugs.

  2020cites this paper
• The potential effects of anticonvulsant drugs on neuropeptides and neurotrophins in pentylenetetrazol kindled seizures in the rat

  2020cites this paper
• Effect of levetiracetam drug on antioxidant and liver enzymes in epileptic patients: case-control study

  2020cites this paper
• Levetiracetam effect on behavioral and electrophysiological parameters in rat model of global brain ischemia.

  2020cites this paper
• CHAPTER 7

  2020cites this paper
• Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis

  2020cites this paper
• Effects of levetiracetam on axon excitability and synaptic transmission at the crayfish neuromuscular junction

  2020cites this paper
• Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?

  2020cites this paper
• Levetiracetam add-on for drug-resistant focal epilepsy.

  2020cites this paper
• An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy.

  2019cites this paper
• Levetiracetam induction of theta frequency oscillations in rodent hippocampus in vitro.

  2019cites this paper
• Comparative efficacy of IV phenytoin, IV valproate and IV levetiracetam in childhood seizures

  2019cites this paper
• Levetiracetam effect and electrophysiological mechanism of action in rats with cobalt-induced chronic epilepsy.

  2019cites this paper
• Safety and Efficacy of Levetiracetam for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review.

  2019cites this paper
• Brivaracetam efficacy and safety in focal epilepsy

  2019influential citation
• A Bioequivalence Study of Two Formulations of Levetiracetam

  2019cites this paper
• The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs.

  2019cites this paper
• Age-Dependency of Levetiracetam Effects on Exocytotic GABA Release from Nerve Terminals in the Hippocampus and Cortex in Norm and After Perinatal Hypoxia

  2019cites this paper
• Anti-epileptic effect of 16-O-acetyldigitoxigenin via suppressing mTOR signaling pathway.

  2019cites this paper
• Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures.

  2018cites this paper
• Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel

  2018cites this paper
• levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• Comparison of effects and electrophysiological mechanisms of action of valproic acid and levetyracetam in an experimental model of focal epilepsy

  2018cites this paper
• Synthesis, anticonvulsant activity, and molecular modeling studies of novel 1-phenyl/1-(4-chlorophenyl)-2-(1H-triazol-1-yl)ethanol ester derivatives

  2018cites this paper
• Levetiracetam-mediated improvement of decreased NMDA-induced glutamate release from nerve terminals during hypothermia.

  2018cites this paper
• Effect of levetiracetam on extracellular amino acid levels in the dorsal hippocampus of rats with temporal lobe epilepsy.

  2018cites this paper
• Disposition of levetiracetam in healthy adult horses

  2018cites this paper
• Drugs Commonly Used to Treat Refractory Status Epilepticus in Clinical Practice

  2017cites this paper
• Multi-scale modeling of altered synaptic plasticity related to Amyloid β effects

  2017cites this paper
• A Review on Pharmacokinetics of Levetiracetam in Neonates.

  2017cites this paper
• Management of Status Epilepticus in the Intensive Care Unit

  2017cites this paper
• Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review.

  2017cites this paper
• Hallucination: A rare complication of levetiracetam theraphy

  2017cites this paper
• Drug-Resistant Epilepsy and Surgery

  2017cites this paper
• Mechanisms of hyperexcitability and efficacy of antiepileptic drugs in hippocampal-entorhinal networks in the Reduced Intensity Status Epilepticus (RISE) model of chronic epilepsy

  2017cites this paper
• Brivaracetam does not modulate ionotropic channels activated by glutamate, γ‐aminobutyric acid, and glycine in hippocampal neurons

  2017cites this paper
• The adverse event profile of brivaracetam: A meta-analysis of randomized controlled trials.

  2017cites this paper
• Status epilepticus in dogs and cats, part 2: treatment, monitoring, and prognosis.

  2017cites this paper
• Evaluation of the relaxant effect of levetiracetam on isolated rat duodenum

  2017cites this paper
• Connecting epilepsy and Alzheimer’s Disease: Multi-scale modeling of normal and pathological rhythmicity and synaptic plasticity related to Amyloidβ (Aβ) effects

  2016cites this paper
• Receptors in Embryonic Mouse Hippocampal Neurons

  2016cites this paper
• Side Effects of Antiepileptic Drugs

  2016cites this paper
• Role of Zinc Supplementation in the Treatment of Levetiracetam-Induced Hair Loss: A Case Series

  2016cites this paper
• Antiepileptic drugs for Tourette's syndrome

  2016cites this paper
• Chapter 2 Connecting epilepsy and Alzheimer ’ s Disease : Modeling of normal and pathological rhythmicity and synaptic plasticity related to Amyloid β ( A β ) effects

  2016cites this paper
• Duration of vaccine-induced immunity

  2016cites this paper
• Antioxidant properties of antiepileptic drugs levetiracetam and clonazepam in mice brain after in vitro-induced oxidative stress

  2016cites this paper
• Polypharmacological Drugs in the Treatment of Epilepsy: The Comprehensive Review of Marketed and New Emerging Molecules.

  2016cites this paper
• Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.

  2016cites this paper
• Synaptic Vesicle Protein 2A as a Novel Pharmacological Target with Broad Potential for New Antiepileptic Drugs

  2016cites this paper
• Part 1: Design, Synthesis, and Evaluation of Novel Gram-positive Antibiotics Part 2: Synthesis of Dihydrobenzofurans Via a New Transition Metal Catalyzed Reaction Part 3: Design, Synthesis, and Evaluation of Bz/gabaa Α6 Positive Allosteric Modulators

  2016cites this paper
• Intravenous levetiracetam treatment in status epilepticus: A prospective study.

  2015cites this paper
• Levetiracetam for the treatment of status epilepticus

  2015cites this paper
• NeuronsReceptors in Embryonic Mouse Hippocampal

  2015cites this paper
• Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy

  2015cites this paper
• Seletracetam enhances short term depression in vitro.

  2015cites this paper
• Antimuscarinic-induced convulsions in fasted animals after food intake: evaluation of the effects of levetiracetam, topiramate and different doses of atropine

  2015cites this paper
• Interactions of levetiracetam with ethosuximide in the mouse 6 Hz psychomotor seizure model – a type II isobolographic analysis

  2015cites this paper